| __timestamp | Galapagos NV | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 18516000 |
| Thursday, January 1, 2015 | 129714000 | 34140000 |
| Friday, January 1, 2016 | 139574000 | 51872000 |
| Sunday, January 1, 2017 | 218502000 | 71772000 |
| Monday, January 1, 2018 | 322876000 | 97501000 |
| Tuesday, January 1, 2019 | 427320000 | 118590000 |
| Wednesday, January 1, 2020 | 523667000 | 169802000 |
| Friday, January 1, 2021 | 491707000 | 192507000 |
| Saturday, January 1, 2022 | 515083000 | 199563000 |
| Sunday, January 1, 2023 | 241294000 | 253598000 |
Unleashing insights
In the competitive world of biotechnology, innovation is the key to success. Over the past decade, Galapagos NV and Xencor, Inc. have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Galapagos NV consistently outpaced Xencor, Inc. in R&D spending, with an average annual investment of approximately 312 million USD, nearly 2.6 times more than Xencor's average of 121 million USD.
However, the trend shifted in 2023 when Xencor, Inc. surpassed Galapagos NV, investing 5% more in R&D. This change highlights Xencor's growing commitment to innovation. As the biotech landscape evolves, these investments will likely play a crucial role in determining which company leads the next wave of breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.